Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer-Reference-Cited by-同舟云学术

Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer

Published:2021-05-08 Issue:7 Volume:60 Page:921-930
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Slørdahl Kathinka S.¹²,Klotz Dagmar³,Olsen Jan-Åge¹,Skovlund Eva⁴,Undseth Christine¹,Abildgaard Heidi Larsen¹,Brændengen Morten¹⁵,Nesbakken Arild²⁵⁶,Larsen Stein Gunnar⁶,Hanekamp Bettina A.⁷,Holmboe Laila⁷,Tvedt Ragnhild¹,Sveen Anita²⁵⁸,Lothe Ragnhild A.²⁵⁸,Malinen Eirik⁹¹⁰,Kaasa Stein¹²,Guren Marianne Grønlie¹⁵^ORCID

Affiliation:

1. Department of Oncology, Oslo University Hospital, Oslo, Norway

2. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

3. Department of Pathology, Oslo University Hospital, Oslo, Norway

4. Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway

5. K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway

6. Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway

7. Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway

8. Department of Molecular Oncology, Oslo University Hospital, Oslo, Norway

9. Department of Physics, University of Oslo, Oslo, Norway

10. Department of Medical Physics, Oslo University Hospital, Oslo, Norway

Funder

Department of Oncology

Oslo University Hospital

Norwegian Cancer Society

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1918763

Reference51 articles.

1. RE: Anal cancer: different epidemiological and clinical definitions

2. Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016

3. Cancer today. WHO and International Agency for Research on Cancer [Internet]. Year 2018. Available from: https://gco.iarc.fr/today/fact-sheets-populations.

4. Combined therapy for cancer of the anal canal

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer;Physica Medica;2023-10

2. A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers;European Journal of Nuclear Medicine and Molecular Imaging;2023-08-26

3. Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer;Acta Oncologica;2023-07-28

4. Magnetic resonance imaging of anal cancer: tumor characteristics and early prediction of treatment outcome;Strahlentherapie und Onkologie;2023-07-10

5. Long-term survival after treatment for primary anal cancer– results from the Swedish national ANCA cohort study;Acta Oncologica;2022-01-31